Following the genericization of blood thinner Plavix and hypertension treatment Avapro/Avalide in major markets across the globe, partners Bristol-Myers Squibb Company ( BMY ) and Sanofi (
Follow this link:
BMY/Sanofi Alliance Modified – Analyst Blog